Join today and have your say! It’s FREE!
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by gojotv!on Jul 30, 2021 10:52am
125 Views
Post# 33631914

RE:RE:RE:News..SZLS Provides Update on Planned Acquisition

RE:RE:RE:News..SZLS Provides Update on Planned AcquisitionYes... Perfect!

Nailbiter1 wrote: Hand in hand... Perfect.





LithLover wrote:

Saturday Aug 14 and Q2 due Monday Aug 16.  

 

Tylerdude wrote: https://irdirect.net/prviewer/release_only/id/4810485


delayed till aug 14

 

 





<< Previous
Bullboard Posts
Next >>